N-terminal degradation of low molecular weight opioid peptides in human cerebrospinal fluid
- 1 August 1990
- journal article
- research article
- Published by Elsevier in Biochemical Pharmacology
- Vol. 40 (3) , 465-472
- https://doi.org/10.1016/0006-2952(90)90544-u
Abstract
No abstract availableThis publication has 37 references indexed in Scilit:
- Cerebrovascular reactivity to angiotensin and angiotensin-converting enzyme activity in cerebrospinal fluidBrain Research, 1988
- Analgesis and convulsant effects of guanidinoethylmercaptosuccinic acid (GEMSA) — A potent enkephalin convertase inhibitorNeuropeptides, 1986
- Endopeptidase in human cerebrospinal fluid which cleaves proenkephalin B opioid peptides at consecutive basic amino acidsBiochemical and Biophysical Research Communications, 1985
- Spontaneous and evoked release of methionine-enkephalin-like material from the rat spinal cord in vivoBrain Research, 1985
- The μ rather than the δ subtype of opioid receptors appears to be involved in enkephalin-induced analgesiaEuropean Journal of Pharmacology, 1984
- Enkephalin degrading enzymes in cerebrospinal fluidLife Sciences, 1983
- BIOGENESIS, RELEASE AND INACTIVATION OF ENKEPHALINS AND DYNORPHINSBritish Medical Bulletin, 1983
- Increased levels of met-enkephalin-like material in the CSF of anaesthetized cats after tooth pulp stimulationBrain Research, 1982
- RAPID INACTIVATION OF ENKEPHALIN-LIKE MATERIAL BY C.S.F. IN CHRONIC SCHIZOPHRENIAThe Lancet, 1978
- Enkephalin-like material in normal human CSF: Measurement and levelsLife Sciences, 1978